Co-Morbidities as Predictors of Airflow Limitation among Smokers in England
The prevalence of co-morbidities among patients with Chronic Obstructive Pulmonary Disease (COPD) is well documented in the literature. Therefore, this pilot study aimed to identify whether co-morbidities screening would enhance COPD case-finding. Smoking patients were approached at Croydon Universi...
Main Authors: | Reem Kayyali, Yusur Hassan, Iman Hesso, Roshan Siva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-05-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | http://www.mdpi.com/2226-4787/6/2/45 |
Similar Items
-
Factors affecting the development of airflow limitation
among South Korean smokers
by: Youngmee Kim, et al.
Published: (2019-03-01) -
Chronic airflow obstruction in Tanzania – a cross-sectional study
by: Thomas Zoller, et al.
Published: (2018-01-01) -
Incidence of bacterial respiratory infection and pneumonia in people with HIV with and without airflow limitation
by: Safura-Luise Heidari, et al.
Published: (2024-02-01) -
Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population
by: Diana A. van der Plaat, et al.
Published: (2019-03-01) -
Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
by: Harries TH, et al.
Published: (2020-01-01)